Journal of Cosmetic Dermatology · 2022 · 15 citations · 25 references
MedicineEndocrinologyAutoimmunityClinical NutritionDiabetologyAutoimmune DiseasesDiabetes MellitusGlucose HomeostasisInsulin ResistanceMetabolic DiseaseMetabolic SyndromeCase-control Study DesignImpaired Glucose ToleranceInsulin Resistance AssessmentInsulin Resistance BiomarkersInsulin Resistance SyndromeLaboratory Plasma Glucose TestingMetabolic Syndrome EpidemiologyMetabolic Syndrome Risk Assessment
BACKGROUND: Autoimmune and metabolic disturbances have been reported in association with vitiligo, highlighting possible systemic associations that should be considered. AIMS: To assess the possible association of metabolic syndrome (MetS) as well as insulin resistance (IR) with vitiligo in different age groups. METHODS: This case-control study included 142 patients with vitiligo aging ≥ 6 years and 142 age- and sex-matched controls. Participants were assessed for MetS using the International Diabetes Federation (IDF) criteria in addition to IR via homeostasis model assessment of IR (HOMA-IR). The study was registered at Clinical Trials.gov, Identifier: NCT03622320, on August 9, 2018. RESULTS: As per the IDF criteria, patients with vitiligo showed significantly more frequent association with high fasting plasma glucose levels, high blood pressure readings, central obesity, dyslipidemia, and MetS than controls (p = 0.020, p = 0.034, p = 0.014, p < 0.001, and p = 0.002, respectively). Moreover, patients with vitiligo have significantly higher levels of fasting insulin and HOMA-IR (p ≤ 0.001). Results obtained from patients with vitiligo and controls with coexistent MetS/IR demonstrated vitiligo as a risk factor for both MetS and IR. Univariate and multivariate logistic regression highlighted that older age was the significant independent predictor for MetS and IR. CONCLUSION: Patients with vitiligo showed a significantly higher incidence of MetS than controls. Vitiligo per se can be considered a risk factor for MetS and IR. Therefore, regular follow-up and early metabolic derangement diagnoses are mandatory.
25
K. G. M. M. Alberti, Paul Zimmet · Diabetic Medicine · 1998 · 15.3K citations
The IDF consensus worldwide definition of the metabolic syndrome
Obesity and metabolism · 2005 · 1.4K citations · Full text
<i>NALP1</i> in Vitiligo-Associated Multiple Autoimmune Disease
Ying Jin, Christina M. Mailloux, Katherine Gowan et al. · New England Journal of Medicine · 2007 · 628 citations · Full text
The estimation of areas of burns
Cc Lund · Medical Entomology and Zoology · 1944 · 567 citations
Medicine, Surgery, Burn Surgery +8